210 related articles for article (PubMed ID: 30015321)
1. Barrett's esophagus and gland cancer - the experience of one center.
Nowicki A; Kula Z; Świerszczyńska A
Pol Przegl Chir; 2018 May; 90(3):19-24. PubMed ID: 30015321
[TBL] [Abstract][Full Text] [Related]
2. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
3. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M
World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
6. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
[TBL] [Abstract][Full Text] [Related]
8. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
Drewitz DJ; Sampliner RE; Garewal HS
Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
[TBL] [Abstract][Full Text] [Related]
9. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
10. [The role of selected risk factors in Barrett's esophagus development].
Kiciński P; Mokrowiecka A; Czkwianianc E; Kolasa-Kicińska M; Wozniakowska-Gesicka T; Małecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):390-4. PubMed ID: 19606681
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
[TBL] [Abstract][Full Text] [Related]
12. Barrett esophagus and adenocarcinoma.
Chen MY; Frederick MG
Radiol Clin North Am; 1994 Nov; 32(6):1167-81. PubMed ID: 7972706
[TBL] [Abstract][Full Text] [Related]
13. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
14. [Columnar-celled metaplasia and adenocarcinoma of the esophagus in inhabitants of the Leningrad oblast (by the data of esophagogastroduodenoscopy)].
Vasilevskiĭ DI; Silant'ev DS; Mikhaleva KV; Priadko AS; Filin AV; Vorob'ev SL; Mednikov SN; Luft AV; Kulagin VI; Bagnenko SF
Vestn Khir Im I I Grek; 2012; 171(6):76-9. PubMed ID: 23488270
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus. Prevalence and incidence of adenocarcinoma.
Williamson WA; Ellis FH; Gibb SP; Shahian DM; Aretz HT; Heatley GJ; Watkins E
Arch Intern Med; 1991 Nov; 151(11):2212-6. PubMed ID: 1953225
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
17. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].
Burdiles P; Csendes A; Smok G; Braghetto I; Korn O
Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
19. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
O'Connor JB; Falk GW; Richter JE
Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
[TBL] [Abstract][Full Text] [Related]
20. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
